EUVIMEDEUVIMED entdecken
Crossref

Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy

Yao Li, Xiao-Jie Ju iD, Han Fu, Chang-Hai Zhou, Yi Gao, Jun Wang, Rui Xie iD, Wei Wang iD, Zhuang Liu iD, Liang-Yin Chu iD

ACS Applied Materials & Interfaces · 11.01.2023 · 15 (1) · 638-650

DOI: 10.1021/acsami.2c19241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 28.12.2022. Verfasst von Yao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Sichuan University, Chengdu610065, China. Hauptthemen laut MEDLINE: Calcitonin, Osteoporosis. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Sichuan University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A composite separable microneedles (MNs) system consisting of silk fibroin (SF) needle tips and hyaluronic acid (HA) base is developed for transdermal delivery of salmon calcitonin (sCT) for therapy of osteoporosis. Poly(ethylene glycol) (PEG) is used to modulate the conformation structure of SF to achieve controllable sustained release of sCT. The prepared MNs can effectively penetrate the skin stratum corneum. After application to the skin, the HA base is dissolved within 2 min, allowing these SF drug depots to be implanted into the skin for controllable sustained release of sCT. The release kinetics of sCT can be controlled by regulating the conformation of SF with PEG and the interaction between sCT peptide and SF proteins. Compared with traditional needle injection, delivery of sCT using optimized HA-PEG/SF MNs shows better trabecular bone repair for ovariectomized-induced osteoporosis in mice. The proposed MNs system provides a new noninjection strategy for therapy of osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalcitoninOsteoporosisMiceAnimalsDelayed-Action PreparationsAdministration, CutaneousDrug Delivery SystemsNeedles

Stichwörter der Autor:innen

controlled-release kineticsosteoporosissalmon calcitoninseparable microneedlestransdermal delivery

Substanzen

salmon calcitoninDelayed-Action PreparationsCalcitonin

Autor:innen und Institutionen

  • School of Chemical Engineering, Sichuan University, Chengdu610065, China.
  • School of Chemical Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu610065, China.
  • West China Hospital of Stomatology, Sichuan University, Chengdu610041, China.

ORCID-Profile: Xiao-Jie Ju, Rui Xie, Wei Wang, Zhuang Liu, Liang-Yin Chu

Förderung

  • Sichuan University
  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Ju, X. J., Fu, H., Zhou, C. H., Gao, Y., Wang, J., Xie, R., Wang, W., Liu, Z., & Chu, L. Y. (2023). Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy. ACS Applied Materials & Interfaces, 15(1), 638-650. https://doi.org/10.1021/acsami.2c19241

Vancouver

Li Y, Ju XJ, Fu H, Zhou CH, Gao Y, Wang J, et al. Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy. ACS Applied Materials & Interfaces. 2023;15(1):638-650. doi:10.1021/acsami.2c19241

BibTeX
@article{Li2023,
  author = {Li, Yao and Ju, Xiao-Jie and Fu, Han and Zhou, Chang-Hai and Gao, Yi and Wang, Jun and Xie, Rui and Wang, Wei and Liu, Zhuang and Chu, Liang-Yin},
  title = {Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {638--650},
  doi = {10.1021/acsami.2c19241}
}
Kostenlos starten →